FreXAla - topical treatment with aromatase inhibitor, 5-alpha reductase inhibitor and alpha lipoic acid in Multiple Symmetric Lipomatosis (MSL)

• Forschungsstelle: INNOSUISSE
• Projektnummer: 130.086 INNO-LS
• Projekttitel Englisch: FreXAla - topical treatment with aromatase inhibitor, 5-alpha reductase inhibitor and alpha lipoic acid in Multiple Symmetric Lipomatosis (MSL)

Schlüsselwörter (Englisch)

Life sciences, Pharmaceuticals

Abstract (Englisch)

Testing delivery and release kinetics of a new proprietary topical treatment with aromatase inhibitor, 5-alpha reductase inhibitor and alpha lipoic acid in the rare and orphan disease Multiple Symmetric Lipomatosis (aka Madelung's disease)